Log In
Print this Print this

cyclosporin (ASD-004)

  Manage Alerts
Collapse Summary General Information
Company Ascendia Pharmaceuticals LLC
DescriptionNano-emulsion formulation of cyclosporin
Molecular Target
Mechanism of Action 
Therapeutic ModalityMacrocycle
Latest Stage of DevelopmentPreclinical
Standard IndicationDry eye
Indication DetailsTreat dry eye syndrome (DES)
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today